Stay updated on Azacitidine, Venetoclax, Pevonedistat Clinical Trial
Sign up to get notified when there's something new on the Azacitidine, Venetoclax, Pevonedistat Clinical Trial page.

Latest updates to the Azacitidine, Venetoclax, Pevonedistat Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check43 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check57 days agoChange DetectedThe study on 'Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia' has been updated to revision v2.14.1 on 2025-01-13, replacing the previous revision v2.14.0 from 2025-01-10.SummaryDifference1.0%
- Check64 days agoChange DetectedThe intervention details for 'Azacitidine, Venetoclax, and Pevonedistat in Treating Patients with Newly Diagnosed Acute Myeloid Leukemia' have been updated to a new version (v2.14.0) with a scheduled date of 2025-01-10, replacing the previous version (v2.13.3) dated 2024-06-24.SummaryDifference2%
- Check93 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
Stay in the know with updates to Azacitidine, Venetoclax, Pevonedistat Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine, Venetoclax, Pevonedistat Clinical Trial page.